There is a paucity of information on the perceptions of community pharmacists about the nature and effectiveness of pharmaceutical care services they provide to people living with dementia in care homes. This paper explores pharmacists’ perceptions of the nature and effectiveness of pharmacy services provided, and their experiences when providing these services. Community pharmacists delivering services to care homes with dementia in Thurrock, Essex and in Medway, Kent, England were invited to participate in the study involving face-to-face interviews. Analysis of semi-structured interviews with 15 community pharmacists revealed that the main pharmaceutical service provided by the pharmacists was prescription processing, normally involving the clinical review and supply of medication into monitored dosage systems (dosette boxes) and delivery to the homes. This was coupled with advice to care homes on the appropriate storage and administration of drugs and appliances supplied, which was in line with the NHS Community Pharmacy Contractual Framework Enhanced Service for care homes. A majority of the community pharmacists interviewed acknowledged that the services they were currently commissioned to provide did not meet the pharmaceutical care needs of dementia patients in care homes, including the monitoring of the appropriateness, safety and effectiveness of drug therapy.
Alzheimer's Disease International. (2016). World Alzheimer Report. Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future. London. Retrieved October 30, 2017, from https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf
2.
Alzheimer's Society. (2007). Home from home: a report highlighting opportunities for improving standards of dementia care in care homes, London. Alzheimer's Society UK.
3.
AndaloD. (2014).
Pharmacists offer a clinical service to vulnerable care home residents. The Pharmaceutical Journal,
292, 313–314. Retrieved from http://dx.doi.org/10.1211/pj.2014.11135788
4.
BarberN.AlldredD.RaynorD.DickinsonR.GarfieldS.JessonB.… ZermanskyA. G. (2009).
Care homes' use of medicines study: Prevalence, causes and potential harm of medication errors in care homes for older people. Quality and Safety in Health Care,
18(5), 341–346. Retrieved from http://dx.doi.org/10.1136/qshc.2009.034231
BowlingA. (2009). Research methods in health.
Maidenhead:
McGraw-Hill Open Univ. Press.
7.
Care Homes & Residential Homes UK – Care Home & Residential Home UK Guide. (2015). Carehome.co.uk. Retrieved October 15, 2015, from http://www.carehome.co.uk/care_search.cfm
ChangF.PatelT.SchulzM. (2015).
The “Rising Tide” of dementia in Canada: What does it mean for pharmacists and the people they care for?Canadian Pharmacists Journal/Revue Des Pharmaciens Du Canada,
148(4), 193–199. Retrieved from http://dx.doi.org/10.1177/1715163515588107
11.
ChildA.ClarkeA.FoxC.MaidmentI. (2012).
A pharmacy led program to review anti-psychotic prescribing for people with dementia. BMC Psychiatry,
12(1). Retrieved from http://dx.doi.org/10.1186/1471-244x-12-155
CrumpK.BooG.LiewF.OlivierT.SoC.SungJ.… WheelerA. (2011).
New Zealand community pharmacists' views of their roles in meeting medicine-related needs for people with mental illness. Research in Social and Administrative Pharmacy,
7(2), 122–133. Retrieved from http://dx.doi.org/10.1016/j.sapharm.2010.03.006
16.
DeeksL.CooperG.DraperB.KurrleS.GibsonD. (2016).
Dementia, medication and transitions of care. Research in Social and Administrative Pharmacy,
12(3), 450–460. Retrieved from http://dx.doi.org/10.1016/j.sapharm.2015.07.002
17.
Department of Health (DOH). (2003). A vision for pharmacy in the new NHS. London: Department of Health.
FurnissL.BurnsA.CraigS.ScobieS.CookeJ.FaragherB. (2000).
Effects of a pharmacist's medication review in nursing homes: Randomised controlled trial. The British Journal of Psychiatry,
176(6), 563–567. Retrieved from http://dx.doi.org/10.1192/bjp.176.6.563
21.
GidmanW. (2011).
Increasing community pharmacy workloads in England: Causes and consequences. International Journal of Clinical Pharmacy,
33(3), 512–520. Retrieved from http://dx.doi.org/10.1007/s11096-011-9498-x
22.
HassellK.SestonE.SchafheutleE.WagnerA.EdenM. (2011).
Workload in community pharmacies in the UK and its impact on patient safety and pharmacists’ well-being: A review of the evidence. Health & Social Care in the Community,
19(6), 561–575. Retrieved from http://dx.doi.org/10.1111/j.1365-2524.2011.00997.x
HilmerS.GnjidicD. (2008).
The effects of polypharmacy in older adults. Clinical Pharmacology & Therapeutics,
85(1), 86–88. Retrieved from http://dx.doi.org/10.1038/clpt.2008.224
25.
JordanS.Gabe-WaltersM.WatkinsA.HumphreysI.NewsonL.SnelgroveS.DennisM. (2015).
Nurse-led medicines' monitoring for patients with dementia in care homes: A pragmatic cohort stepped wedge cluster randomised trial. Plos One,
10(10), e0140203. Retrieved from http://dx.doi.org/10.1371/journal.pone.0140203
26.
KrskaJ. (2001).
Pharmacist-led medication review in patients over 65: A randomized, controlled trial in primary care. Age and Ageing,
30(3), 205–211. Retrieved from http://dx.doi.org/10.1093/ageing/30.3.205
MaidmentI.AstonL.HiltonA.IqbalN.ChildA.ShawR. (2016).
Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD): A qualitative study. BMJ Open,
6, e010278. DOI: 10.1136/bmjopen-2015-010278.
29.
MalekN.GreeneJ. (2014).
Cognition enhancers for the treatment of dementia. Scottish Medical Journal,
60(1), 44–49. Retrieved from http://dx.doi.org/10.1177/0036933014561948
O’BrienJ.BurnsA. (2010).
Clinical practice with anti-dementia drugs: A revised (second) consensus statement from the British Association for Psychopharmacology. Journal of Psychopharmacology,
25(8), 997–1019. Retrieved from http://dx.doi.org/10.1177/0269881110387547
33.
Office for National Statistics. (2011). Interim based subnational population projections, October 2011.
34.
PrenticeA.WrightD. (2014).
Reducing antipsychotic drugs in care homes. Nursing Times,
110(22), 12–15.
35.
PrinceM.KnappM.GuerchetM.McCroneP.MatthewP.Comas-HerreraA.… SalimkumarD. (2014). Dementia UK: Second edition – Overview (2nd ed., p. 61).
London:
Alzheimer’s Society.
QatoD.AlexanderG.ContiR.JohnsonM.SchummP.LindauS. (2008).
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. Journal of the American Medical Association,
300(24), 2867. Retrieved from http://dx.doi.org/10.1001/jama.2008.892
39.
RichmondS.MortonV.CrossB.WongI.RussellI.PhilipsZ.… CampionP. (2010).
Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. British Journal of General Practice,
60(570), 10–19. Retrieved from http://dx.doi.org/10.3399/bjgp09x473295
RPS Scotland. (2012). Improving pharmaceutical care in care homes.
Edinburgh:
Royal Pharmaceutical Society.
43.
SharpeS. (2013). Future funding deals for community pharmacists will reward quality and service provision. The Pharmaceutical Journal,
291, 484. Retrieved from http://dx.doi.org/10.1211/pj.2013.11129862.
44.
Task Force on Medicines Partnership and the National Collaborative Medicines Management Services Programme. (2002). Room for review. A guide to medication review: the agenda for patients, practitioners and managers. Keele: Keele University. Retrieved September 14, 2017, from http://www.keele.ac.uk/schools/pharm/npcplus/medicinespartner/roomforreview.htm
45.
TongA.SainsburyP.CraigJ. (2007).
Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care,
19(6), 349–357. Retrieved from http://dx.doi.org/10.1093/intqhc/mzm042
46.
United Nations. (2009). World population and ageing 2009.
New York, NY:
United Nations.
47.
VarnishJ. (1998).
Drug pushers or health care professionals: The public's perceptions of pharmacy as a profession. International Journal of Pharmacy Practice,
6(1), 13–21. Retrieved from http://dx.doi.org/10.1111/j.2042-7174.1998.tb00911.x
